drugset / Trial / NCT04440371

Phototherapy Combination With Topicals in Vitiligo

NCT04440371

RandomizedParallel-groupOpen-labelTreatment

Summary

Patients will be included in a randomized controlled clinical trial, will enroll only adult vitiligo patients with surface area of at least 10% who are being followed in the outpatient dermatology clinics of King Abdullah University Hospital (KAUH) and are planned to start on phototherapy Narrow Band Ultraviolet light B (NBUVB), regardless if they have previous treatment for their disease, one month wash off period will be given for patients who are already on phototherapy or other treatments for vitiligo.

Timeline

Start
2020-06-21
Primary completion
2023-07-30
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified Topical
Subject Calcipotriol Small molecule Topical
Subject Tacrolimus Small molecule 0.1 % Topical

Indications